OBJECTIVE: To assess the incidence of osteoradionecrosis (ORN) of the temporal bone after surgery with radiotherapy for malignant parotid tumors. SETTING: A tertiary care, academic medical center. PATIENTS: All patients who underwent surgical resection with postoperative radiotherapy (RT) for a malignant parotid tumor between July 1988 and July 2007. INTERVENTIONS: A retrospective chart analysis to determine the extent of surgery, the RT parameters, and the incidence of ORN of the temporal bone. MAIN OUTCOME MEASURES: The incidence of ORN in 3 subgroups of patients. RESULTS: The 221 patients with malignant parotid tumors who underwent surgical resection with postoperative RT were divided into groups 1, parotidectomy only; 2, parotidectomy with mastoidectomy; and 3, parotidectomy with subtotal petrosectomy. The overall incidence of temporal bone ORN in group 1 was 2 (2%) of 106; in group 2, 8 (13%) of 64; and in group 3, 0 (0%) of 51. CONCLUSION: The incidence of temporal bone ORN is higher after mastoidectomy for facial nerve identification or resection in patients undergoing parotidectomy with postoperative radiotherapy. Oversew of the ear canal with mastoid obliteration should be considered in this subgroup of patients to avoid this long-term complication of radiotherapy used in the treatment of malignant parotid tumors.
OBJECTIVE: To assess the incidence of osteoradionecrosis (ORN) of the temporal bone after surgery with radiotherapy for malignant parotid tumors. SETTING: A tertiary care, academic medical center. PATIENTS: All patients who underwent surgical resection with postoperative radiotherapy (RT) for a malignant parotid tumor between July 1988 and July 2007. INTERVENTIONS: A retrospective chart analysis to determine the extent of surgery, the RT parameters, and the incidence of ORN of the temporal bone. MAIN OUTCOME MEASURES: The incidence of ORN in 3 subgroups of patients. RESULTS: The 221 patients with malignant parotid tumors who underwent surgical resection with postoperative RT were divided into groups 1, parotidectomy only; 2, parotidectomy with mastoidectomy; and 3, parotidectomy with subtotal petrosectomy. The overall incidence of temporal bone ORN in group 1 was 2 (2%) of 106; in group 2, 8 (13%) of 64; and in group 3, 0 (0%) of 51. CONCLUSION: The incidence of temporal bone ORN is higher after mastoidectomy for facial nerve identification or resection in patients undergoing parotidectomy with postoperative radiotherapy. Oversew of the ear canal with mastoid obliteration should be considered in this subgroup of patients to avoid this long-term complication of radiotherapy used in the treatment of malignant parotid tumors.
Authors: Salmaan Ahmed; Nakul Gupta; Jackson D Hamilton; Adam S Garden; Paul W Gidley; Lawrence E Ginsberg Journal: J Comput Assist Tomogr Date: 2014 Sep-Oct Impact factor: 1.826
Authors: Jie Min Soh; Vishal Deepak D'Souza; Gopal Krishna Sarepaka; Win Nie Ng; Chun Suan Ong; Wong Kein Low Journal: Clin Exp Otorhinolaryngol Date: 2012-04-30 Impact factor: 3.372
Authors: Benjamin D Lovin; Mike Hernandez; Hunter Elms; Jonathan S Choi; Nathan R Lindquist; Amy C Moreno; Marc-Elie Nader; Paul W Gidley Journal: Laryngoscope Date: 2021-07-20 Impact factor: 2.970
Authors: Gabriela Studer; Marius Bredell; Stephan Studer; Gerhard Huber; Christoph Glanzmann Journal: Strahlenther Onkol Date: 2015-08-12 Impact factor: 3.621